350 related articles for article (PubMed ID: 21090173)
1. Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells.
Yerlikaya A; DoKudur H
Mol Biol (Mosk); 2010; 44(5):859-66. PubMed ID: 21090173
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of eIF2alpha in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase.
Yerlikaya A; Kimball SR; Stanley BA
Biochem J; 2008 Jun; 412(3):579-88. PubMed ID: 18290760
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy targeting ectopic ATP synthase and 26S proteasome induces ER stress in breast cancer cells.
Chang HY; Huang TC; Chen NN; Huang HC; Juan HF
Cell Death Dis; 2014 Nov; 5(11):e1540. PubMed ID: 25429617
[TBL] [Abstract][Full Text] [Related]
4. Expression of heme oxygenase-1 in response to proteasomal inhibition.
Yerlikaya A
Protein Pept Lett; 2012 Dec; 19(12):1330-3. PubMed ID: 22670665
[TBL] [Abstract][Full Text] [Related]
5. Translation initiation control by heme-regulated eukaryotic initiation factor 2alpha kinase in erythroid cells under cytoplasmic stresses.
Lu L; Han AP; Chen JJ
Mol Cell Biol; 2001 Dec; 21(23):7971-80. PubMed ID: 11689689
[TBL] [Abstract][Full Text] [Related]
6. The proteasome inhibitor, MG132, promotes the reprogramming of translation in C2C12 myoblasts and facilitates the association of hsp25 with the eIF4F complex.
Cowan JL; Morley SJ
Eur J Biochem; 2004 Sep; 271(17):3596-611. PubMed ID: 15317596
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade.
Yerlikaya A; Erin N
Int J Mol Med; 2008 Dec; 22(6):817-23. PubMed ID: 19020781
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition.
Wu WT; Chi KH; Ho FM; Tsao WC; Lin WW
Biochem J; 2004 May; 379(Pt 3):587-93. PubMed ID: 14731112
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.
Navas TA; Nguyen AN; Hideshima T; Reddy M; Ma JY; Haghnazari E; Henson M; Stebbins EG; Kerr I; O'Young G; Kapoun AM; Chakravarty S; Mavunkel B; Perumattam J; Luedtke G; Dugar S; Medicherla S; Protter AA; Schreiner GF; Anderson KC; Higgins LS
Leukemia; 2006 Jun; 20(6):1017-27. PubMed ID: 16617327
[TBL] [Abstract][Full Text] [Related]
10. Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells.
Codony-Servat J; Tapia MA; Bosch M; Oliva C; Domingo-Domenech J; Mellado B; Rolfe M; Ross JS; Gascon P; Rovira A; Albanell J
Mol Cancer Ther; 2006 Mar; 5(3):665-75. PubMed ID: 16546981
[TBL] [Abstract][Full Text] [Related]
11. Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: a consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2alpha (eIF2alpha)-kinase (PERK) and general control nonderepressible-2 eIF2alpha kinase (GCN2), and global translational shutoff.
Acharya P; Engel JC; Correia MA
Mol Pharmacol; 2009 Sep; 76(3):503-15. PubMed ID: 19520899
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation.
Kao C; Chao A; Tsai CL; Chuang WC; Huang WP; Chen GC; Lin CY; Wang TH; Wang HS; Lai CH
Cell Death Dis; 2014 Nov; 5(11):e1510. PubMed ID: 25375375
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β.
Choi CH; Lee BH; Ahn SG; Oh SH
Biochem Biophys Res Commun; 2012 Feb; 418(4):759-64. PubMed ID: 22310719
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
Shi YY; Small GW; Orlowski RZ
Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
[TBL] [Abstract][Full Text] [Related]
15. Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity.
Combaret V; Boyault S; Iacono I; Brejon S; Rousseau R; Puisieux A
Mol Cancer; 2008 Jun; 7():50. PubMed ID: 18534018
[TBL] [Abstract][Full Text] [Related]
16. A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line.
Yerlikaya A; Okur E; Baykal AT; Acılan C; Boyacı I; Ulukaya E
J Proteomics; 2015 Jan; 113():315-25. PubMed ID: 25305590
[TBL] [Abstract][Full Text] [Related]
17. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
[TBL] [Abstract][Full Text] [Related]
18. Heme-regulated inhibitor: an overlooked eIF2α kinase in cancer investigations.
Yerlikaya A
Med Oncol; 2022 May; 39(5):73. PubMed ID: 35568791
[TBL] [Abstract][Full Text] [Related]
19. Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication.
Neznanov N; Dragunsky EM; Chumakov KM; Neznanova L; Wek RC; Gudkov AV; Banerjee AK
PLoS One; 2008 Apr; 3(4):e1887. PubMed ID: 18382670
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.
Nawrocki ST; Carew JS; Dunner K; Boise LH; Chiao PJ; Huang P; Abbruzzese JL; McConkey DJ
Cancer Res; 2005 Dec; 65(24):11510-9. PubMed ID: 16357160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
